about
Bisphenol A, Bisphenol S, and 4-Hydroxyphenyl 4-Isoprooxyphenylsulfone (BPSIP) in Urine and Blood of CashiersAnalysis of T-cell repertoire diversity in Wiskott-Aldrich syndrome.The involvement of human RECQL4 in DNA double-strand break repair.Autoimmunity in Wiskott-Aldrich syndrome.Pharmacokinetics of bisphenol A in humans following a single oral administration.Associations of subjective vitality with DNA damage, cardiovascular risk factors and physical performance.The Impact of Environmental and Endogenous Damage on Somatic Mutation Load in Human Skin FibroblastsGene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.Base excision repair of oxidative DNA damage and association with cancer and agingSomatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism.Human T cell immunosenescence and inflammation in aging.Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial.Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family.Aging, inflammation and the environment.Crohn's disease IRGM risk alleles are associated with altered gene expression in human tissuesToll-like Receptor 4 Pathway Polymorphisms Interact with Pollution to Influence Asthma Diagnosis and SeverityDifferential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineagesCartilage hair hypoplasia mutations that lead to RMRP promoter inefficiency or RNA transcript instabilityEchocardiographic findings in classical and hypermobile Ehlers-Danlos syndromesEpigenetic Enzymes, Age, and Ancestry Regulate the Efficiency of Human iPSC ReprogrammingDNA damage responses in murine Pre-B cells with genetic deficiencies in damage response genesThe COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action
P50
Q28391633-ABD37DFC-DD46-4F4B-A080-ADBC4ADEE9CDQ33367749-F5C562FA-0E26-4D85-BFFF-9E4069AC1DE9Q33539979-F3D53644-F1B6-4540-8D22-D8F4C90DABE1Q35159550-94E2B4DA-A656-44B7-BBAD-D11C928322E9Q35675920-47845DCD-B97D-4CD2-A8B9-5961F455B232Q36100869-B554C36D-90F3-4AED-B00B-961557B10AD7Q36175992-31919E2C-3587-48A8-A9CD-3FB4732BCC43Q36370817-30189AF5-B4A5-479F-8C80-0C47C1F08059Q37090426-BFEF6C46-2365-4463-A13B-D4A6B89B0CA1Q37111771-16EF2EA2-E349-47BF-9CD7-7688158D4693Q39451386-84AB6BA0-9D7D-4DFC-AC3A-F265C837DFCCQ44232574-4C42C220-166C-4D57-8D9B-B6D1B87F09D1Q47606166-BBA69B3D-91D9-4469-95B8-8A72B51A6BCBQ49595178-D2E707F0-1DEE-4685-B70D-89F7E1A18657Q58592067-B6FC2668-D1DB-4679-A3D0-75323DCFEA46Q58714204-9D98C5D3-6163-40CF-89E6-C677AB29D2AAQ79077280-3C58ABAC-8039-4781-AEFD-74E2096524C1Q81442921-803D514B-976C-42E8-A57E-9CDE707FD572Q81624742-23875DA8-5792-4BE3-924D-248D88527520Q91175529-C1C88BD8-09B4-4C5B-A8DD-6F4C1A89A13CQ91400947-45074CE9-A2C9-493A-83F0-A4C1EB32FFDFQ94552258-14F9C495-CCF6-4234-BBE6-E4804816EF35
P50
description
researcher, ORCID id # 0000-0002-9133-7906
@en
wetenschapper
@nl
name
Shepherd H Schurman
@ast
Shepherd H Schurman
@en
Shepherd H Schurman
@es
Shepherd H Schurman
@nl
type
label
Shepherd H Schurman
@ast
Shepherd H Schurman
@en
Shepherd H Schurman
@es
Shepherd H Schurman
@nl
prefLabel
Shepherd H Schurman
@ast
Shepherd H Schurman
@en
Shepherd H Schurman
@es
Shepherd H Schurman
@nl
P106
P1153
7003884815
P31
P496
0000-0002-9133-7906